| Organism name | Piper philippinum | 
|---|---|
| Genus | Piper | 
| Family | Piperaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Piper | 
|---|---|
| Linked NCBI taxonomy ID | 13215 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Piperaceae | 
|---|---|
| ID | 16739 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | Magnoliophyta | 
|---|---|
| ID | 3398 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00004573   | 3,7,4'-Tri-O-methylkaempferol / Kaempferol 3,7,4'-trimethyl ether / 5-Hydroxy-3,7,4'-trimethoxyflavone / 5-Hydroxy-3,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one | CHEMBL77686 | No. 35 | No. 15 |   | |||
| C00003674   | Stigmasterol / beta-Stigmasterol | CHEMBL66943 CHEMBL186373 CHEMBL400247 CHEMBL1568947 | D013265 | 5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |   | 
| C00003672   | Sitosterol / beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol | CHEMBL221542 CHEMBL1398443 CHEMBL1875388 | 17 / 19 / 12 | No. 53 | No. 11 |   | ||
| C00034357   | (22E,24S)-Stigmast-4,22-dien-3-one | CHEMBL307549 | No. 53 | No. 11 |   | |||
| C00027470   | Piperolactam A | CHEMBL387864 | C457227 | No. 125 |   | |||
| C00034356   | Kusunokinin / (-)-Kusunokinin | No. 223 | No. 21 |   | ||||
| C00034632   | Piperphilippinin I | No. 223 | No. 21 |   | ||||
| C00034633   | Piperphilippinin II / (-)-Piperphilippinin II | No. 223 | No. 21 |   | ||||
| C00034355   | Haplomyrfolin / (-)-Haplomyrfolin | No. 223 | No. 21 |   | ||||
| C00000606   | (-)-Matairesinol | CHEMBL425148 | C068935 | 1 / 0 / 0 | No. 223 | No. 21 |   | |
| C00034637   | Piperphilippinin VI | No. 282 | No. 21 |   | ||||
| C00012483   | Betula pubescens / Caryophyllene oxide / trans-Caryophyllene oxide / beta-Caryophyllene epoxide / (-)-Epoxydihydrocaryophyllene / 6,7-Epoxy-3(15)-caryophyllene / (-)-beta-Caryophyllene epoxide / 4beta,5alpha-Epoxycaryophyllene / Caryophyllene 4beta,5alpha-epoxide | CHEMBL399036 CHEMBL508894 CHEMBL479134 CHEMBL1513806 CHEMBL1553274 | 3 / 1 / 3 | No. 500 |   | |||
| C00002608   | Hinokinin / Hinoquinin / (-)-Hinokinin / (-)-Hinoquinin | CHEMBL180970 CHEMBL182073 CHEMBL242011 | C475934 | 2 / 1 / 1 | No. 629 | No. 21 |   | |
| C00023758   | Ergosta-4,6,8(14),22-tetraen-3-one | CHEMBL1801892 CHEMBL2040598 | C015860 | No. 768 |   | |||
| C00002636   | Anisaldehyde / p-Anisaldehyde | CHEMBL161598 | C024896 | 11 / 18 / 13 | 1 / 0 | No. 1003 |   | |
| C00034635   | Piperphilippinin IV / (-)-Piperphilippinin IV | No. 1029 | No. 21 |   | ||||
| C00034386   | 3,4-Methylenedioxycinnamic acid | No. 2200 |   | |||||
| C00034395   | (E)-Methyl 4-methoxycinnamate / 4-Methoxy-trans-cinnamic acid | No. 2416 |   | |||||
| C00002757   | 4-Methoxycinnamaldehyde / p-Methoxycinnamaldehyde | CHEMBL452173 | No. 2748 | No. 6 |   | |||
| C00029536   | p-Anisic acid / 4-Methoxybenzoic acid | CHEMBL21932 | C004520 | 3 / 2 / 3 | No. 2930 |   | ||
| C00034636   | Piperphilippinin V | No. 3222 |   | |||||
| C00034385   | 3,4-Methylenedioxycinnamaldehyde | No. 3773 |   | |||||
| C00002666   | Piperonal | CHEMBL271663 | C005454 | 3 / 4 / 4 | No. 4093 |   | ||
| C00031034   | Piperonylic acid / 3,4-Methylenedioxybenzoic acid | CHEMBL573781 | C005455 | 2 / 0 / 0 | No. 4093 |   | ||
| C00034634   | Piperphilippinin III / (-)-Piperphilippinin III | No. 4573 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002608 C00003672 C00012483 | 0 / 1 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002636 C00002666 C00031034 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00002636 C00003672 | 1 / 1 | 
| P06746 | DNA polymerase beta | Enzyme | C00003672 C00003674 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 C00012483 | 1 / 1 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002608 C00003672 | 1 / 0 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002636 C00003672 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00002636 C00003672 | 4 / 2 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002666 C00003672 | 1 / 1 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 C00012483 | 0 / 1 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002636 | 0 / 0 | 
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00003674 | 0 / 0 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00029536 | 1 / 2 | 
| P04278 | Sex hormone-binding globulin | Secreted protein | C00000606 | 0 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002636 | 0 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00029536 | 0 / 0 | 
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 | 
| P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 | 
| P00734 | Prothrombin | S1A | C00003672 | 4 / 2 | 
| P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002636 | 1 / 1 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002636 | 5 / 3 | 
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002636 | 1 / 1 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00031034 | 0 / 0 | 
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00002636 | 3 / 1 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002666 | 3 / 3 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 | 
| P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00003674 | 0 / 0 | 
| P51580 | Thiopurine S-methyltransferase | Enzyme | C00029536 | 1 / 1 | 
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 | 
| P10275 | Androgen receptor | NR3C4 | C00002636 | 3 / 4 | 
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003674 | 0 / 0 | 
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003674 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 | C00002636 | 
| 10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 | C00003674 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #300068 | Androgen insensitivity syndrome; ais | P10275 | 
| #312300 | Androgen insensitivity, partial; pais | P10275 | 
| #218030 | Apparent mineralocorticoid excess; ame | P80365 | 
| %606641 | Body mass index; bmi | P37231 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #613163 | Gaba-transaminase deficiency | P80404 | 
| #137800 | Glioma susceptibility 1; glm1 | P37231 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #601665 | Obesity | P37231 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 | P10275 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601367 | Stroke, ischemic | P00734 | 
| #271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd | P51649 | 
| #610460 | Thiopurine s-methyltransferase deficiency | P51580 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth | P10828 | 
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth | P10828 | 
| #145650 | Thyroid hormone resistance, selective pituitary; prth | P10828 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00024 | Prostate cancer | P10275
                            (related) | 
| H00062 | Spinal and bulbar muscular atrophy (SBMA) | P10275
                            (related) | 
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) | P10275
                            (related) | 
| H00609 | 46,XY disorders of sex development (Other) | P10275
                            (related) | 
| H00249 | Thyroid hormone resistance syndrome | P10828
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00032 | Thyroid cancer | P37231
                            (related) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P37231
                            (related) | 
| H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) | P51580
                            (related) | 
| H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency | P51649
                            (related) | 
| H00259 | Apparent mineralocorticoid excess syndrome | P80365
                            (related) | 
| H01257 | GABA-transaminase deficiency | P80404
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) |